Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) saw a significant growth in short interest during the month of August. As of August 15th, there was short interest totaling 68,200 shares, agrowthof176.1% from the July 31st total of 24,700 shares. Based on an average trading volume of 51,800 shares, the short-interest ratio is presently 1.3 days. Based on an average trading volume of 51,800 shares, the short-interest ratio is presently 1.3 days.
Edap Tms Stock Performance
Shares of EDAP stock traded down $0.01 on Tuesday, reaching $2.73. The stock had a trading volume of 36,060 shares, compared to its average volume of 90,770. The company has a quick ratio of 1.05, a current ratio of 1.51 and a debt-to-equity ratio of 0.04. The firm's 50-day moving average is $1.61 and its two-hundred day moving average is $1.82. The firm has a market capitalization of $102.08 million, a price-to-earnings ratio of -4.48 and a beta of -0.21. Edap Tms has a 12 month low of $1.21 and a 12 month high of $3.29.
Institutional Trading of Edap Tms
A number of hedge funds have recently added to or reduced their stakes in the stock. Jane Street Group LLC grew its holdings in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock worth $69,000 after purchasing an additional 73,361 shares during the period. Simplicity Wealth LLC bought a new stake in shares of Edap Tms in the second quarter valued at approximately $54,000. BNP Paribas Financial Markets raised its position in shares of Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock valued at $108,000 after purchasing an additional 25,650 shares during the period. Millennium Management LLC increased its holdings in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after acquiring an additional 33,558 shares during the period. Finally, Cetera Investment Advisers increased its holdings in Edap Tms by 33.9% during the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock worth $147,000 after acquiring an additional 19,000 shares during the period. Institutional investors and hedge funds own 62.74% of the company's stock.
Wall Street Analyst Weigh In
EDAP has been the subject of several recent research reports. Wall Street Zen initiated coverage on shares of Edap Tms in a research report on Thursday, May 15th. They set a "hold" rating for the company. Piper Sandler cut shares of Edap Tms from an "overweight" rating to a "neutral" rating in a research report on Thursday, May 15th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Edap Tms presently has an average rating of "Hold" and a consensus price target of $8.50.
View Our Latest Report on EDAP
About Edap Tms
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Featured Articles
Before you consider EDAP TMS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EDAP TMS wasn't on the list.
While EDAP TMS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.